US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,176.53

+4.650.40%

Number of Gainers:6

Number of Losers:1

Number of Flat:- -

PE:- -

High:1,184.60

Open:1,174.28

Low:1,169.27

Close:1,171.87

Volume:37.78M

Turnover:3.26B

Market Cap:1.25T

Float Cap:1.18T

Loading ...

Novo Nordisk Stock (NVO) Slides on Rival Weight Loss Pill News

Eli Lilly Stock Rises. Its Pill Has Ramped Up the Weight-Loss War With Novo Nordisk. -- Barrons.com

Pfizer Announces 100 Layoffs in Bothell, Washington

Viking Therapeutics Shares Down 3.8% After Rival Eli Lilly's Glp-1 Pill Helps Cut Body Weight in Late Stage Study of Diabetes Patients

THOMSON REUTERS

Lilly Pill Cuts Body Weight by 10.5% in Patients with Type 2 Diabetes

Eli Lilly (LLY.US) Oral Weight-Loss Drug Phase 3 Data Released: 10.5% Average Weight Reduction, Global Regulatory Submissions to Begin

These Stocks Are Moving the Most Today: AT&T, EchoStar, AMD, Lilly, Interactive Brokers, Talen Energy, and More -- Barrons.com

Viking Therapeutics: What's Next?

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'

Benzinga_recent_news

Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuits

FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles

European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

MT Newswires Live

Amgen Says US FDA Broadens Approved Use of Repatha

MT Newswires Live

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday

MT Newswires Live

BRIEF-Amgen Inc - FDA Broadens Repatha Use For Cardiovascular Risk

Eli Lilly and Company to Participate in Morgan Stanley's 23rd Annual Global Healthcare Conference

Amgen Inc - Update Removes Prior Cv Disease Diagnosis Requirement

THOMSON REUTERS

Royalty Pharma Stock (RPRX) Rises as it Seals $950M Cancer Royalties Deal with Amgen

Royalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra

Royalty Pharma Acquires Royalty Interest in Amgen's Imdelltra for $885 Million, with Option for Additional $65 Million Purchase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4599/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1176.5248,"timestamp":1756317650808,"preClose":1171.8711,"halted":0,"volume":37779815,"delay":0,"changeRate":0.003971,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":4.653687,"latestTime":"08-27 14:00:51 EDT","open":1174.2782,"high":1184.6003,"low":1169.2704,"amount":3261001034.122241,"amplitude":0.013082,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756324800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.219752,"peRate":24.342188,"turnoverRate":0.00357,"increases":6,"decrements":1,"flats":0,"marketCap":1249704665248,"floatMarketCap":1177093507936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1184.6003,"amplitude":0.013082,"preClose":1171.8711,"low":1169.2704,"pbRate":"8.219752","latestPrice":1176.5253,"volume":37779164,"delay":0,"open":1174.2782,"prevYearClose":1305.0607,"prevWeekClose":1162.718,"prevMonthClose":1136.9344,"prevQuarterClose":1245.5326,"fiveDayClose":1144.6144,"twentyDayClose":1172.8523,"sixtyDayClose":1229.9794,"secType":"PLATE","market":"US","turnoverRate":0.00357,"peRate":24.342188,"marketCap":1249704665248,"floatMarketCap":1177093507936,"timestamp":1756317649639,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":6,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562731753","title":"Novo Nordisk Stock (NVO) Slides on Rival Weight Loss Pill News","url":"https://stock-news.laohu8.com/highlight/detail?id=2562731753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562731753?lang=en_us&edition=fundamental","pubTime":"2025-08-27 00:10","pubTimestamp":1756224658,"startTime":"0","endTime":"0","summary":"Novo Nordisk stock slipped on Tuesday alongside news of advancements from a weight loss rival.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-slides-on-rival-weight-loss-pill-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-slides-on-rival-weight-loss-pill-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU0154236417.USD","LU1093756325.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVO","BK4007","BK4599","BK4588","BK4585","LU1093756168.USD"],"gpt_icon":0},{"id":"2562989753","title":"Eli Lilly Stock Rises. Its Pill Has Ramped Up the Weight-Loss War With Novo Nordisk. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2562989753","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562989753?lang=en_us&edition=fundamental","pubTime":"2025-08-27 00:07","pubTimestamp":1756224420,"startTime":"0","endTime":"0","summary":"Eli Lilly stock was rising in early trading Tuesday after it posted fresh data on its experimental weight-loss pill.The pharma giant said the latest trial showed the medication resulted in up to 10.5% weight loss in overweight or obese patients with Type 2 diabetes in a late-stage trial. The firm continues to battle with rival Novo Nordisk for market share in the lucrative GLP-1 space.The data readout for the pill orforglipron comes less than three weeks after the drugmaker released results of a similar trial in patients with obesity or overweight without diabetes that didn't meet investors' expectations and sent shares falling 14% on the day. That study showed a mean body weight reduction of 12.4% over 72 weeks for patients on the highest dose, compared with patients on the placebo, who lost 0.9%.Lilly said the safety profile of orforglipron was consistent with injectable GLP-1 medicines such as its Mounjaro and Zepbound","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382058.USD","LU2456880835.USD","BK4588","LU2746668461.USD","LU0323591593.USD","LU0820561909.HKD","NVO","SGXZ99366536.SGD","LU0354030438.USD","LU0889565916.HKD","LU2471134796.USD","BK4585","LU2471134879.HKD","LU0354030511.USD","LU2324357040.USD","LU0006306889.USD","BK4599","LU2361044865.SGD","LU2552382215.SGD","LU2236285917.USD","LU1057294990.SGD","LLY","LU1917777945.USD","IE00B4R5TH58.HKD","BK4534","SGXZ57979304.SGD","LU2471134952.CNY","LU0109391861.USD","SG9999001176.USD","IE0002141913.USD","LU1093756325.SGD","IE00B1BXHZ80.USD","LU2491049909.HKD","LU2361044949.HKD","LU2237438978.USD","LU1988902786.USD","LU2237443895.HKD","LU0106261372.USD","LU1712237335.SGD","IE00BZ1G4Q59.USD","LU0786609619.USD","LU1814569148.SGD","LU1868836591.USD","SGXZ31699556.SGD","LU2461242641.AUD","LU2552382132.HKD","LU2491050071.SGD","LU1868837136.USD","LU2750360997.AUD","LU0823434740.USD"],"gpt_icon":1},{"id":"1128987483","title":"Pfizer Announces 100 Layoffs in Bothell, Washington","url":"https://stock-news.laohu8.com/highlight/detail?id=1128987483","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128987483?lang=en_us&edition=fundamental","pubTime":"2025-08-26 23:01","pubTimestamp":1756220491,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) shares declined 0.14% during early Tuesday trading following the company's announcement of 100 job cuts in Bothell, Washington, as the pharmaceutical industry faces widespread...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU0289739699.SGD","BK4550","LU1894683264.USD","LU0985481810.HKD","BK4568","LU1066053197.SGD","IE00BBT3K403.USD","BK4534","SG9999011175.SGD","LU1057294990.SGD","BK4585","LU0225771236.USD","PFE","SG9999001176.USD","LU1883839398.USD","LU0122379950.USD","IE00B19Z3581.USD","LU1894683348.USD","LU0456855351.SGD","SG9999003800.SGD","IE00B19Z3B42.SGD","SG9999013999.USD","LU0306806265.USD","IE000M9KFDE8.USD","LU0868494617.USD","BK4588","LU1066051498.USD","SGXZ57979304.SGD","LU0321505868.SGD","LU1023059063.AUD","BK4599","IE00BLSP4239.USD","BK4581","BK4592","LU0321505439.SGD","BK4007","BK4533","IE0002270589.USD","LU0058720904.USD","SG9999002232.USD","LU0225284248.USD","SG9999002224.SGD","LU0306807586.USD","SG9999001176.SGD","LU0234572021.USD","LU0170899867.USD"],"gpt_icon":0},{"id":"2562734206","title":"Viking Therapeutics Shares Down 3.8% After Rival Eli Lilly's Glp-1 Pill Helps Cut Body Weight in Late Stage Study of Diabetes Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2562734206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562734206?lang=en_us&edition=fundamental","pubTime":"2025-08-26 21:48","pubTimestamp":1756216086,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nFWN3UI0S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VKTX","BK4599","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2562787050","title":"Lilly Pill Cuts Body Weight by 10.5% in Patients with Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2562787050","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562787050?lang=en_us&edition=fundamental","pubTime":"2025-08-26 21:45","pubTimestamp":1756215917,"startTime":"0","endTime":"0","summary":"Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a9ac7eade038fc683a99ac802b0e049f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nL1N3UH0IM:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Lilly Pill Cuts Body Weight by 10.5% in Patients with Type 2 Diabetes","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","GB00BDT5M118.USD","IE00BJT1NW94.SGD","LLY","LU0882574055.USD","LU2417539215.USD","LU0316494557.USD","LU2237443549.SGD","LU0061475181.USD","LU2552382215.SGD","LU1291159041.SGD","LU1988902786.USD","LU1267930730.SGD","LU2112291526.USD","LU1814569148.SGD","LU2471134796.USD","SG9999015952.SGD","LU0106261372.USD","LU0640476718.USD","LU1551013425.SGD","LU1548497426.USD","BK4007","LU0256863811.USD","LU1280957306.USD","LU1868836757.USD","SG9999001176.SGD","LU0820561909.HKD","BK4533","LU2237443465.HKD","LU0354030438.USD","LU0323591593.USD","IE00B2B36J28.USD","IE0004445239.USD","SG9999017495.SGD","LU0094547139.USD","BK4581","LU2237443622.USD","LU0203202063.USD","LU1057294990.SGD","LU2746668461.USD","SG9999015986.USD","LU2063271972.USD","SG9999015945.SGD","LU0786609619.USD","LU1551013342.USD","LU0122379950.USD","BK4599","LU1983299246.USD","LU2264538146.SGD","LU1989771016.USD"],"gpt_icon":0},{"id":"1173018605","title":"Eli Lilly (LLY.US) Oral Weight-Loss Drug Phase 3 Data Released: 10.5% Average Weight Reduction, Global Regulatory Submissions to Begin","url":"https://stock-news.laohu8.com/highlight/detail?id=1173018605","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173018605?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:26","pubTimestamp":1756211191,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY.US) announced Tuesday that its oral weight-loss therapy orforglipron achieved its primary endpoint in a Phase 3 trial, with the company set to advance global regulatory submissions for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1562215406f683d19f5eb2345c8cc126","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2461242641.AUD","LU0234572021.USD","LU2468319806.SGD","LU2471134879.HKD","SG9999014914.USD","LU1064131342.USD","LLY","LU0823416689.USD","LU1551013425.SGD","LU2211815571.USD","LU2023250504.SGD","BK4007","LU2237443978.SGD","LU0266013472.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1712237335.SGD","IE00BK4W5L77.USD","LU2361044949.HKD","LU0786609619.USD","LU0354030438.USD","LU0672654240.SGD","LU1814569148.SGD","SG9999001176.USD","LU0198837287.USD","LU2237443549.SGD","LU0456855351.SGD","LU0203202063.USD","LU0106261372.USD","LU1267930730.SGD","LU1069344957.HKD","BK4534","LU0203201768.USD","IE0009355771.USD","LU0238689110.USD","LU1868836591.USD","LU0823434740.USD","LU1623119135.USD","LU2417539215.USD","LU0640476718.USD","SG9999001176.SGD","SG9999015978.USD","LU2746668461.USD","LU2237438978.USD","SGXZ31699556.SGD","BK4516","LU2491050071.SGD","BK4599","LU0079474960.USD","LU2063271972.USD","LU2491049909.HKD","LU0471298777.SGD","IE00B2B36J28.USD","LU1366192091.USD","LU1720051017.SGD","LU2462157665.USD","LU2750360997.AUD","LU0466842654.USD","LU2491050154.USD","LU2552382215.SGD","LU1280957306.USD","BK4588","LU1057294990.SGD","LU2237443465.HKD","SG9999015945.SGD","SGXZ99366536.SGD","LU1093756168.USD","LU0943347566.SGD","SG9999014906.USD","LU2361044865.SGD","LU0316494557.USD","LU2746668974.SGD","LU0385154629.USD","LU2456880835.USD","LU0689472784.USD","LU1917777945.USD","LU0097036916.USD","LU2237443895.HKD","LU1551013342.USD","LU0889565916.HKD","LU1868836757.USD","SG9999017495.SGD","LU0289739699.SGD","LU1093756325.SGD","LU0820561818.USD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00BK4W5M84.HKD","LU2471134523.USD","LU2357305700.SGD","LU0006306889.USD","LU1989771016.USD","LU0096364046.USD","LU0823434583.USD","LU0882574139.USD","LU0114720955.EUR","LU0320765992.SGD","SG9999018857.SGD","SGXZ51526630.SGD","LU2750360641.GBP","LU2324357040.USD","SG9999013999.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU2112291526.USD","LU0109391861.USD","LU2237443622.USD","BK4585","LU1291159041.SGD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU0882574055.USD","LU0256863811.USD","LU2237443382.USD","LU2471134796.USD","LU1988902786.USD","LU2236285917.USD","LU2602419157.SGD","LU1548497426.USD","IE0004445239.USD","LU1035775433.USD","LU1804176565.USD","LU2361045086.USD","SGXZ57979304.SGD","SG9999014898.SGD","SG9999018865.SGD","LU0708995401.HKD","LU0471298694.HKD","BK4533","LU0820561909.HKD","LU0432979614.USD","LU0061475181.USD","SG9999015952.SGD","SG9999014880.SGD","LU2471134952.CNY","SG9999015986.USD","LU2360106947.USD","LU2264538146.SGD","LU0320765059.SGD","LU1983299246.USD","LU1232071149.USD","LU2108987350.USD","BK4581","LU2265009873.SGD","LU0094547139.USD","SGXZ81514606.USD","LU2552382132.HKD","GB00BDT5M118.USD","LU1868837136.USD","IE00BJLML261.HKD","IE00B1BXHZ80.USD","LU0122379950.USD","LU1127390331.HKD","LU0256863902.USD","LU0058720904.USD","LU1720051108.HKD","LU0354030511.USD","LU2106854487.HKD","LU2552382058.USD","LU1061106388.HKD","LU1974910355.USD","IE0002141913.USD","LU0323591593.USD","LU1868836914.USD"],"gpt_icon":1},{"id":"2562973359","title":"These Stocks Are Moving the Most Today: AT&T, EchoStar, AMD, Lilly, Interactive Brokers, Talen Energy, and More -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2562973359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562973359?lang=en_us&edition=fundamental","pubTime":"2025-08-26 19:37","pubTimestamp":1756208220,"startTime":"0","endTime":"0","summary":"Stock futures fell Tuesday after President Donald Trump said he had fired Lisa Cook from her job as a Federal Reserve governor, stoking concerns about the central bank's independence.AT&T rose 0.6% after the telecommunications company said it intended to buy spectrum licenses from EchoStar for $23 billion. AT&T said the purchase would give it the exclusive rights to a slice of the radio frequency spectrum in specific areas. AT&T said the transaction would help it to \"maintain long-term leadership in advanced connectivity across 5G and fiber.\" EchoStar shares jumped 60%.Interactive Brokers was rising 4.2% after S&P Dow Jones Indices announced the online broker would be replacing  Walgreens Boots Alliance in the S&P 500 at the open of trading on Thursday. Walgreens is being acquired by the private-equity firm Sycamore Partners in a deal expected to be completed soon.Talen Energy jumped 4.3% after the power generator was selected to replace Interactive Brokers in the S&P MidCap 400 index,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1935042488.USD","LU2746668974.SGD","BK4608","LU1551013425.SGD","LU0154236417.USD","AMD","LU0683600562.USD","SG9999014542.SGD","LU1989772840.SGD","SATS","LU2290526834.HKD","SNVD.UK","SG9999018857.SGD","LU0456855351.SGD","T","LU1791710400.SGD","IE00BJJMRY28.SGD","LU0077335932.USD","IE00BN29S564.USD","NVDS.UK","NVDX","TLN","LU0238689110.USD","LU2028103732.USD","LU1923622291.USD","3NVD.UK","IE00BFSS8Q28.SGD","NVD","NVDD","LU0471298777.SGD","2NVD.UK","BK4592","NVDS","NVIW.SI","HK0000306701.USD","LU0316494557.USD","NVDU","NVDY","NVD2.UK","BK4599","IBKR","LU2098885051.SGD","GFS","LU0211328371.USD","SG9999002232.USD","NVD3.UK","LU2326559502.SGD"],"gpt_icon":1},{"id":"2562782421","title":"Viking Therapeutics: What's Next?","url":"https://stock-news.laohu8.com/highlight/detail?id=2562782421","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562782421?lang=en_us&edition=fundamental","pubTime":"2025-08-26 18:15","pubTimestamp":1756203300,"startTime":"0","endTime":"0","summary":"Viking's 40% crash over fixable dosing issues ignores its best-in-class 12.2% oral weight loss and Phase 3 momentum.","market":"fut","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F830764%2Fresearcher.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F830764%2Fresearcher.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/08/26/viking-therapeutics-whats-next/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4585","BK4588","BK4139","BK4599","VKTX"],"gpt_icon":1},{"id":"2562224579","title":"Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'","url":"https://stock-news.laohu8.com/highlight/detail?id=2562224579","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562224579?lang=en_us&edition=fundamental","pubTime":"2025-08-26 02:31","pubTimestamp":1756146660,"startTime":"0","endTime":"0","summary":"The Trump administration may remove COVID-19 vaccines from the U.S. market as RFK Jr.'s allies gain influence at HHS, with a new vaccine task force led by a known skeptic.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/25/Covid-19-Vaccine.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/25/Covid-19-Vaccine.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/large-cap/25/08/47316871/trump-administration-plans-to-pull-covid-19-vaccines-off-market-within-months","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["SGXZ57979304.SGD","SG9999001176.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU0058720904.USD","BK4548","LU1023059063.AUD","SG9999003800.SGD","BK4007","SG9999013999.USD","BK4534","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0306807586.USD","BK4588","LU0306806265.USD","NVAX","LU1883839398.USD","BK4592","BK4581","LU1894683348.USD","LU0456855351.SGD","BK4585","BNTX","BK4139","LU0225284248.USD","LU1057294990.SGD","LU1066051498.USD","PFE","LU1066053197.SGD","SG9999002224.SGD","BK4535","LU0868494617.USD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","SG9999002232.USD","BK4550","BK4599","LU1894683264.USD","IE00BLSP4239.USD","LU0234572021.USD","BK4568","BK4533","LU0321505868.SGD","IE00B19Z3581.USD","LU0225771236.USD","LU0985481810.HKD","IE0002270589.USD","SG9999011175.SGD","LU0170899867.USD"],"gpt_icon":1},{"id":"2562622486","title":"Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuits","url":"https://stock-news.laohu8.com/highlight/detail?id=2562622486","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562622486?lang=en_us&edition=fundamental","pubTime":"2025-08-26 02:27","pubTimestamp":1756146452,"startTime":"0","endTime":"0","summary":"Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuitsPlaintiffs claim Depo-Provera causes brain-impacting tumorsFDA rejected Pfizer's request to add tumor warning, company says","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL6N3UH0JI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","BK4568","SG9999003800.SGD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU1023059063.AUD","PFE","SG9999001176.SGD","BK4581","LU0456855351.SGD","BK4534","LU1057294990.SGD","LU0225284248.USD","LU1894683264.USD","LU0225771236.USD","LU0058720904.USD","LU0321505868.SGD","SGXZ57979304.SGD","LU1883839398.USD","LU0234572021.USD","LU0321505439.SGD","BK4550","IE000M9KFDE8.USD","LU0306806265.USD","SG9999011175.SGD","LU1894683348.USD","BK4592","LU0306807586.USD","IE00BLSP4452.SGD","SG9999001176.USD","BK4585","IE00BBT3K403.USD","LU0289739699.SGD","SG9999013999.USD","BK4588","BK4007","BK4533","BK4599","LU1066051498.USD","LU0985481810.HKD","SG9999002224.SGD","LU0868494617.USD","SG9999002232.USD","IE00BLSP4239.USD","IE0002270589.USD","LU0122379950.USD","LU0170899867.USD"],"gpt_icon":1},{"id":"2562622175","title":"FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles","url":"https://stock-news.laohu8.com/highlight/detail?id=2562622175","media":"Benzinga","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562622175?lang=en_us&edition=fundamental","pubTime":"2025-08-26 01:59","pubTimestamp":1756144740,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration  has identified repeated quality control failures, including foreign particle contamination, inadequate investigations, and insufficient corrective actions at the Novo Nordisk A/S NVO operated facility in Bloomington, Indiana.In 2024, Novo Nordisk acquired three fill-finish sites from Novo Holdings A/S for $11 billion. The acquisition was part of a larger deal where Novo Holdings acquired Catalent, Inc. CTLT.The three sites, located in Anagni, Italy, Brussels, Belgium, and Bloomington, Indiana, specialize in the sterile filling of drugs.Also Read: Weighing The Costs: Obesity Drug Users Make Financial Sacrifices As Coverage Tightens. The company’s internal records revealed multiple deviations involving extrinsic contamination, such as cat hair and unidentified particles found during 100% manual visual inspections.The company pointed to FDA observations from a general site inspection at Catalent’s Indiana filler, which is responsible for the EYLEA HD","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/25/Novo-Nordisk-Advertising-Logo-On-Facade-.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/25/Novo-Nordisk-Advertising-Logo-On-Facade-.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/08/47316099/fda-flags-alarming-contamination-at-novo-nordisk-indiana-plant-including-cat-hair-bacteria-and-foreign-particles","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4599","BK4588","BK4532","BK4007","BK4585","NVO","LU1093756325.SGD","LU0154236417.USD","LU1093756168.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2562773228","title":"European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2562773228","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562773228?lang=en_us&edition=fundamental","pubTime":"2025-08-25 22:54","pubTimestamp":1756133649,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week marginally lower late Monday morning, declining 0.3% to 1,539.71 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Argenx  and internet browser company Opera , which rose 6.4% and 3% respectively. They were followed by medical device maker EDAP TMS  and pharmaceutical company Novo Nordisk , which increased  2.2% and 2% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and semiconductor company Sequans Communications , which dropped 3.5% and 2.9% respectively. They were followed by biotech firms BioNTech  and Evaxion , which were down 2.2% each.From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group  and Biodexa Pharmaceuticals , which advanced 5.9% and 2% respectively. They were followed by biopharmaceutical companies  NuCana  and Adaptimmune Therapeutic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMRN","BK4588","BDRX","IE00BFTCPJ56.SGD","BK4568","IE00BZ1G4Q59.USD","CLLS","ARGX","BK4548","EVAX","ADAP","LU0154236417.USD","LU1093756325.SGD","NCNA","BK7104","BK4139","SLN","BK4505","EDAP","IE00BJJMRZ35.SGD","LU0109394709.USD","AKTX","BK4117","BK4585","BK4551","BK4141","LU0320765992.SGD","MREO","BK4107","NVO","BK4082","BK4599","OPRA","IE00BKVL7J92.USD","BK4007","SQNS","BNTX","LU1829250122.USD","BK4023","NVO.AU","BK4535","GSK","LU0889565916.HKD","IE0009355771.USD","IE00BJT1NW94.SGD","AFG","GSK.UK","IE0002141913.USD","IE00B4R5TH58.HKD","LU1093756168.USD"],"gpt_icon":1},{"id":"2562247520","title":"Amgen Says US FDA Broadens Approved Use of Repatha","url":"https://stock-news.laohu8.com/highlight/detail?id=2562247520","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562247520?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:40","pubTimestamp":1756129209,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) said Monday that the US Food and Drug Administration has broadened the approved use of Repatha to include adults at increased risk for major adverse cardiovascular events due to uncontrol","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","LU1983299246.USD","BK4566","LU0320765992.SGD","LU1571399168.USD","BK4534","LU0889565916.HKD","BK4599","AMGN","SG9999001440.SGD","LU2242646821.SGD","BK4139","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4581","LU0058720904.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","IE00BJT1NW94.SGD","BK4585","LU1057294990.SGD","LU2112291526.USD","LU1023059063.AUD","IE0002141913.USD","BK4588","BK4533","LU0122379950.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2242652126.USD","LU0868494617.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2562324229","title":"Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2562324229","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562324229?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:22","pubTimestamp":1756128164,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to lower pre-bell Monday, with the Health Care Select Sector SPDR Fund  inactive and the iShares Biotechnology ETF  down 0.2%.Argenx  stock was nearly 4% higher after the company said a phase 3 study of its drug Vyvgart met its primary endpoint in treating patients with AChR-Ab seronegative generalized myasthenia gravis, an autoimmune disease.Axogen  shares were down more than 10% after the company said the US Food and Drug Administration has extended the review deadline for its marketing application for the Avance Nerve Graft by three months.BeOne Medicines  shares were up more than 2% after the company said it has agreed to sell its royalty rights, excluding China, on Amgen's  lung cancer drug, Imdelltra, to Royalty Pharma  for up to $950 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","BK4581","LU2112291526.USD","XLV","IE00BJT1NW94.SGD","BK4534","IE00B4R5TH58.HKD","BK4139","AXGN","BK4505","BK4082","LU0289739699.SGD","LU0889565916.HKD","IE00BFTCPJ56.SGD","BK4533","IE00BJJMRZ35.SGD","SG9999001440.SGD","BK4585","BK4599","IE0009355771.USD","LU0122379950.USD","LU2242646821.SGD","LU0868494617.USD","ARGX","LU1983299246.USD","LU0320765992.SGD","BK4007","RPRX","LU0058720904.USD","LU2468319806.SGD","BK4588","LU1023059063.AUD","LU1571399168.USD","LU2242652126.USD","ONC","LU1061106388.HKD","LU1057294990.SGD","IBB","LU0109394709.USD","IE0002141913.USD","LU2089984988.USD","BK4566","BK4526","AMGN"],"gpt_icon":0},{"id":"2562244275","title":"BRIEF-Amgen Inc - FDA Broadens Repatha Use For Cardiovascular Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2562244275","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562244275?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:01","pubTimestamp":1756126896,"startTime":"0","endTime":"0","summary":"BRIEF-Amgen Inc - FDA Broadens Repatha Use For Cardiovascular RiskAug 25 (Reuters) - Amgen Inc AMGN.O:AMGEN INC - FDA BROADENS REPATHA USE FOR CARDIOVASCULAR RISKAMGEN INC - UPDATE REMOVES PRIOR CV DI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH0HF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","IE0009355771.USD","BK4139","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1061106388.HKD","BK4533","IE00BFTCPJ56.SGD","LU1571399168.USD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","LU0109394709.USD","LU2468319806.SGD","LU0868494617.USD","BK4566","SG9999001440.SGD","AMGN","LU0320765992.SGD","IE00BJT1NW94.SGD","BK4599","LU2242652126.USD","BK4581","BK4585","LU0289739699.SGD","LU1983299246.USD","IE00B4R5TH58.HKD","LU2112291526.USD","LU0889565916.HKD","LU2089984988.USD","BK4534","IE0002141913.USD","LU2242646821.SGD","BK4588"],"gpt_icon":0},{"id":"2562624477","title":"Eli Lilly and Company to Participate in Morgan Stanley's 23rd Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2562624477","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562624477?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:01","pubTimestamp":1756126868,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025. Jacob Van Naarden, executive vice president and president of Lilly Oncology, along with David Hyman, M.D., Lilly's chief medical officer, will engage in a fireside chat during the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eli Lilly and Company published the original content used to generate this news brief via PR Newswire  on August 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL9HCXyZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU2456880835.USD","LU0795875169.SGD","SG9999015952.SGD","LU1868837136.USD","LU0266013472.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","LU1974910355.USD","LU1989772923.USD","LU0114720955.EUR","IE00B2B36J28.USD","IE00BJLML261.HKD","LU1280957306.USD","LU1720051108.HKD","SG9999015978.USD","SG9999015986.USD","BK4007","LU1668664300.SGD","IE0002141913.USD","SG9999018865.SGD","LU1244550577.SGD","BK4599","LU1127390331.HKD","LU0256863902.USD","LU1720051017.SGD","IE0009355771.USD","IE00B1BXHZ80.USD","LU1064131342.USD","LU2237443622.USD","LU1244550494.USD","LU1162221912.USD","LU2237438978.USD","LU0672654240.SGD","LU0795875086.SGD","LU0158827781.USD","LU2236285917.USD","BK4585","LU2471134952.CNY","MS","LU0109394709.USD","LLY","LU2237443895.HKD","LU0256863811.USD","LU2361045086.USD","SG9999014906.USD","SG9999017495.SGD","LU1093756168.USD","LU0314104364.USD","LU1366192091.USD"],"gpt_icon":1},{"id":"2562244162","title":"Amgen Inc - Update Removes Prior Cv Disease Diagnosis Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2562244162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562244162?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:00","pubTimestamp":1756126833,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH0HF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","BK4585","IE0002141913.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","BK4599","LU1571399168.USD","IE00B2B36J28.USD","LU0122379950.USD","BK4588","LU2089984988.USD","BK4139","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0868494617.USD","LU2242646821.SGD","AMGN","BK4581","LU2468319806.SGD","BK4534","IE00BJT1NW94.SGD","LU2112291526.USD","LU0320765992.SGD","SG9999001440.SGD","IE0009355771.USD","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1983299246.USD","LU0109394709.USD","BK4566","BK4533","LU2242652126.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2562249988","title":"Royalty Pharma Stock (RPRX) Rises as it Seals $950M Cancer Royalties Deal with Amgen","url":"https://stock-news.laohu8.com/highlight/detail?id=2562249988","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562249988?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:54","pubTimestamp":1756122870,"startTime":"0","endTime":"0","summary":"Shares in Royalty Pharma ($RPRX) were higher today after snapping up a royalty interest in pharmaceutical group Amgen’s ($AMGN) new cancer drug. Lu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/royalty-pharma-stock-rprx-rises-as-it-seals-950m-cancer-royalties-deal-with-amgen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/royalty-pharma-stock-rprx-rises-as-it-seals-950m-cancer-royalties-deal-with-amgen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4588","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0868494617.USD","IE0002141913.USD","LU2468319806.SGD","LU2089984988.USD","BK4566","IE00B4R5TH58.HKD","RPRX","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0289739699.SGD","BK4534","LU2242652126.USD","LU2112291526.USD","LU0122379950.USD","LU1023059063.AUD","BK4533","LU1983299246.USD","BK4585","LU2242646821.SGD","BK4007","LU1571399168.USD","LU0320765992.SGD","BK4599","AMGN","SG9999001440.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU1057294990.SGD","BK4139","LU0889565916.HKD","LU1061106388.HKD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2562248583","title":"Royalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra","url":"https://stock-news.laohu8.com/highlight/detail?id=2562248583","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562248583?lang=en_us&edition=fundamental","pubTime":"2025-08-25 18:15","pubTimestamp":1756116918,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) announced that it has acquired a royalty interest in Amgen’s (AMGN) Imdelltra, a first-in-class DLL3 targeting bispecific T-c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/royalty-pharma-confirms-acquisition-of-royalty-interest-in-amgens-imdelltra-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/royalty-pharma-confirms-acquisition-of-royalty-interest-in-amgens-imdelltra-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4007","IE00BFTCPJ56.SGD","BK4534","IE0002141913.USD","LU2112291526.USD","LU1983299246.USD","LU0109394709.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4585","LU0889565916.HKD","LU0122379950.USD","LU1571399168.USD","LU2468319806.SGD","IE00B2B36J28.USD","BK4533","LU0868494617.USD","SG9999001440.SGD","LU2242652126.USD","LU2242646821.SGD","AMGN","BK4599","LU0289739699.SGD","RPRX","LU0058720904.USD","LU1057294990.SGD","IE0009355771.USD","LU1061106388.HKD","BK4566","LU2089984988.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4581"],"gpt_icon":0},{"id":"2562521073","title":"Royalty Pharma Acquires Royalty Interest in Amgen's Imdelltra for $885 Million, with Option for Additional $65 Million Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2562521073","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562521073?lang=en_us&edition=fundamental","pubTime":"2025-08-25 18:10","pubTimestamp":1756116612,"startTime":"0","endTime":"0","summary":"Royalty Pharma Acquires Royalty Interest in Amgen's Imdelltra for $885 Million, with Option for Additional $65 Million Purchase. Royalty Pharma plc has announced the acquisition of a royalty interest in Amgen's Imdelltra, a pioneering immunotherapy for extensive-stage small cell lung cancer, from BeOne Medicines. The deal, valued at up to $950 million, includes an upfront payment of $885 million. BeOne retains the option to sell an additional portion of its royalty to Royalty Pharma for up to $65 million within the next 12 months. The transaction enhances Royalty Pharma's portfolio diversification and aligns with its strategy of acquiring royalties on transformative life sciences products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL2HrPgl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","LU1571399168.USD","BK4533","LU0889565916.HKD","LU2095319765.USD","AMGN","LU1061106388.HKD","IE0002141913.USD","BK4599","BK4566","IE00B64PRP62.GBP","BK4581","IE00B4R5TH58.HKD","LU2089984988.USD","LU2210149790.SGD","LU0122379950.USD","LU1983299246.USD","BK4534","IE00BJT1NW94.SGD","LU1023059063.AUD","IE00BFTCPJ56.SGD","IE00BGHQF748.EUR","LU1057294990.SGD","LU2242652126.USD","IE00BKPKM429.USD","LU2468319806.SGD","BK4139","IE00B3QW5Z07.USD","LU0320765992.SGD","LU2242646821.SGD","IE00B2B36J28.USD","LU0314104364.USD","LU0868494617.USD","LU0289739699.SGD","BK4588","LU0058720904.USD","LU2112291526.USD","IE0009355771.USD","BK4112","SG9999001440.SGD","BK4585","BK4007","IE00BJJMRZ35.SGD","LU0109394709.USD","NDAQ","LU2210150020.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":2,"totalSize":213,"code":"91000000","status":"200"}]}}